The Principal Investigator Role

Similar documents
Research Staff Training

STANDARD OPERATING PROCEDURE SOP 325

Document Title: Document Number:

Document Title: GCP Training for Research Staff. Document Number: SOP 005

SOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY. Contact Jess Bisset, Research Operations Manager x20227

Trial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs

Document Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator

STANDARD OPERATING PROCEDURE SOP 715. Principles of Clinical Research Laboratory Practice

Quality Assurance in Clinical Research at RM/ICR. GCP Compliance Team, Clinical R&D

Standard Operating Procedure (SOP)

Gaining NHS Trust R&D Approvals

Standard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH. Chief and Principal Investigators of research sponsored and/or hosted by UHBristol

Standard Operating Procedure Research Governance

Standard Operating Procedure (SOP) Research and Development Office

Corporate. Research Governance Policy. Document Control Summary

Trial Management: Trial Master Files and Investigator Site Files

Research Governance Framework 2 nd Edition, Medicine for Human Use (Clinical Trial) Regulations 2004

CLINICAL RESEARCH POLICY

Informed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019

STANDARD OPERATING PROCEDURE

Standard Operating Procedure. Essential Documents: Setting Up a Trial Master File. SOP effective: 19 February 2016 Review date: 19 February 2018

STANDARD OPERATING PROCEDURE

ACTIONS/PSOP/001 Version 1.0 Page 2 of 6

European network of paediatric research (EnprEMA)

Version Number: 004 Controlled Document Sponsor: Controlled Document Lead:

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

Auditing of Clinical Trials

STANDARD OPERATING PROCEDURE

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

Once the feasibility assessment has been conducted the study team will be notified via (Appendix 3) of the outcome and whether the study is;

R. Fay, Research Governance & GCP Manager K. Mahiouz, Clinical Trials Facilitator E. Clough, R&D Governance Operations Manager

Progress Review. Launch Meeting 3 rd April 2014, Lucas House, Birmingham

NHS REC Applications

RESEARCH GOVERNANCE POLICY

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

PERFORMANCE IN INITIATING AND DELIVERING CLINICAL RESEARCH INFORMATION SUBMISSION GUIDELINES

Standard Operating Procedure (SOP) for Reporting Urgent Safety Measures in Clinical Research

This Agreement dated DD/MM/YYYY (the Effective Date ) is between

STANDARD OPERATING PROCEDURE

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

Sponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law

Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research

STANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager

MHRA Findings Dissemination Joint Office Launch Jan Presented by: Carolyn Maloney UHL R&D Manager

SOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup

NIHR Guideline B01 R&D Operational Capability Statement for Dorset HealthCare University NHS Foundation Trust

TRAINING REQUIREMENTS FOR RESEARCH STAFF, INCLUDING GOOD CLINICAL PRACTICE (GCP)

Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026

Research Policy. Date of first issue: Version: 1.0 Date of version issue: 5 th January 2012

Research & Development. Case Report Form SOP. J H Pacynko and J Illingworth. Research, pharmacy and R&D staff

Standard Operating Procedure:

Document Title: Training Records. Document Number: SOP 004

Joint R&D Support Office SOP S-2011 UHL

Standard Operating Procedure (SOP) Research and Development Office

Investigator Site File Standard Operating Procedure (SOP)

The START project: Getting research into the patient pathway

Joint Statement on the Application of Good Clinical Practice to Training for Researchers

ABMU R&D Operational Framework

PERFORMANCE IN INITIATING CLINICAL RESEARCH (PI) CLINICAL TRIAL ADJUSTMENT PROCESS HRA APPROVED TRIALS

Document Title: Study Data SOP (CRFs and Source Data)

SOP-QA-28 V2. Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head of School

Document Title: Investigator Site File. Document Number: 019

Research Design Service support for NIHR i4i applications.

Document Title: Recruiting Process. Document Number: 011

Marie-Claire Rickard, RG and GCP Manager Jimena Lovos, Quality Assurance Manager Elizabeth Clough, R&D Governance Operations Manager

STH Researcher. Recording of research information in patient case notes

MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS Memorandum of understanding between MHRA, COREC and GTAC

RESEARCH AND DEVELOPMENT POLICY

Research & Development Operational Capability Statement (RDOCS) Report written by:

Safety Reporting in Clinical Research Policy Final Version 4.0

Keele Clinical Trials Unit

PREDNOS 2 Newsletter. randomised controlled trial (RCT).

Version Number: 003. On: September 2017 Review Date: September 2020 Distribution: Essential Reading for: Information for: Page 1 of 13

Keele Clinical Trials Unit

Research & Development Quality Manual

Details: Approval: Distribution & Storage: Pharmacovigilance for Researchers for UoL / LTHT Sponsored CTIMPs. Standard Operating Procedure

Standard Operating Procedure

Document Title: File Notes. Document Number: 024

Trust Board Meeting in Public: Wednesday 11 July 2018 TB NIHR Clinical Research Network Thames Valley and South Midlands Progress Report

Monitoring Clinical Trials

M. Rickard, Research Governance and GCP Manager R. Fay Research Governance and GCP Manager Elizabeth Clough, Governance Operations Manager

STANDARD OPERATING PROCEDURE

RD SOP12 Research Passport Honorary Contracts / Letters of Access

RESEARCH GOVERNANCE GUIDELINES

How to optimise research support and funding via the UKCRN

National Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP)

The changing regulatory and governance environment. for health research across the UK. a guide for researchers. November 2009 v.1

Advanced Professional Module Clinical Research (2016) Approved by GMC on 14 July 2016 and launched September 2016

Risk Assessment. Version Number 1.0 Effective Date: 21 st March Sponsored Research

Document Title: Informed Consent for Research Studies

Guidance for MRC units on HTA licence applications for storage of human samples for research purposes

Risk Assessment and Monitoring

GCP Training for Research Staff. Document Number: 005

The NIHR Clinical Research Network

STANDARD OPERATING PROCEDURE SOP 205

Research Adverse Event and Safety Reporting Procedures Outcome Statement: Title:

1. INTRODUCTION 2. SCOPE 3. PROCESS

Document Title: Research Database Application (ReDA) Document Number: 043

Course program. Good Clinical Practice (GCP) course for surgeons

The Northern Ireland Clinical Research Network. Guidance Document

Transcription:

The Principal Investigator Role Jo Rodda Consultant in Old Age Psychiatry, NELFT North Thames CRN Dementia Specialty Lead

What is a Principal Investigator? The person responsible for the conduct of a research study at an individual site The nature of the role varies enormously between studies e.g. more responsibility for interventional studies compared to observational studies

The process of research in the NHS Stage 1: Idea, design and planning

The process of research in the NHS Stage 1: Idea, design and planning What is the problem? Identify research question Develop methodology Write protocol

The process of research in the NHS Stage 1: Idea, design and planning Stage 2: Applications and approvals

The process of research in the NHS Stage 1: Idea, design and planning Stage 2: Applications and approvals Stage 3: Study set-up

The process of research in the NHS Stage 1: Idea, design and planning Stage 2: Applications and approvals Stage 3: Study set-up Stage 4: Study conduct, recruitment and data collection

The process of research in the NHS Stage 1: Idea, design and planning Stage 2: Applications and approvals Stage 3: Study set-up Stage 4: Study conduct, recruitment and data collection Stage 5: Analysis and results

NIHR portfolio studies NIHR Clinical Research Network supports infrastructure for research in NHS NIHR Clinical Research Network portfolio High quality research Of clear value and relevance to the NHS Have some of funding provided by NIHR or other organisations The research standards that must be met are the same regardless of whether a portfolio study

Standards applying to research 1964: Declaration of Helsinki Practical standards for research built on Nuremburg code 1996: ICH Guideline for good clinical practice 2001: EU Clinical trials directive minimum set of standards for all EU countries Adopted into UK law as Medicines for Human Use (Clinical Trials) Regulations 2004 Updated 2006 to reflect EU Good Clinical Practice directive

Research Governance Framework Research Governance Framework for Health and Social Care 2005 Sets out standards for clinical research in NHS in England Requires that all research in NHS is carried out to same high standard No matter what focus or methodology

What are CTIMPs? CTIMP Clinical trial of an investigational medicinal product Regulated by the MHRA (Medicines and Healthcare Products Regulatory Agency) The competent authority for ensuring that regulations are applied to clinical trials conducted in the UK

What s a non-ctimp Non-CTIMPs are anything that isn t a CTIMP e.g. Questionnaire studies Data analysis studies Research using material donated from a Research Tissue Bank Research into psychological interventions Standard of conduct the same for CTIMPs and non-ctimps Some of the approval and reporting requirements that apply to CTIMPs do not apply to non-ctimps

Responsibilities Sponsor Usually an NHS Trust, University, pharma or med tech company Overall responsibility for the study but can delegate functions

Responsibilities Sponsor Chief investigator Primary responsibility for conduct of the study at all sites Can delegate some duties but is still responsible for them

Responsibilities Sponsor Chief investigator Principal Investigator Responsible for initiation and conduct of the study at their site Can delegate some responsibilities to the study team but remains responsible for those functions

Responsibilities Sponsor CI PI PI PI Site Team Site Team Site Team

Approvals Health Research Authority (HRA) approval Issues single approval that summates all other approvals Favourable ethical opinion From research ethics committee For CTIMPs MHRA (medicines and products regulatory authority) Registered with European Union Drug Regulating Authorities Clinical Trials (EudraCT) database Some other specialist approvals E.g. gene therapy, radioactive substances

Study set-up (at each site) From site being considered to being ready to go PI responsible with support of study team Site identification Assessment of capacity and capability Practical arrangements Exchange agreements Initiation and start recruitment

Site file PI keeps file of study related documentation e.g. Protocol Patient info sheets Consent forms Data collection tools for study Templates for patient invite letters, GP letters Letters of approval CVs of site team Relevant local SOPs Correspondence with sponsor Delegation of duties log Modifications to documents need REC approval before use

During the delivery of the study Maintaining site file Secure storage Maintenance and storage of patient level documentation Delivering study in accordance with study protocol Reporting process Reporting of adverse events Duties can be delegated

Delegation of duties PI can delegate activities in the protocol

PIC sites PIC = Participant Identification Centre Identification of participants who then are put in touch with study team at a study site No consent or procedures at the PIC site No benefit in terms of R&D targets Can help to foster research active environment People can also access studies at other sites via Join Dementia Research (JDR)

Survey of North Thames consultant psychiatrists research activity June 2015 NELFT, ELFT, C&I, BEH 130 responses

Time dedicated to research in job plan?

Time per week engaged in research activity

Time willing to dedicate to research informally

Other survey findings 81% agreed that research should be part of day to day clinical practice 80% agreed that they wanted to be involved in clinical research 59% agreed they would know how to go about getting involved 55% agreed that they understood what being a PI would involve 10% agreed that they had time for research within day to day clinical work

So can I take on a role as a PI? Dementia and Physical Activity Study (DAPA) 16 week RCT of exercise in dementia Delivered by NELFT physiotherapists with backfill for their clinical time Lead physiotherapist was PI Supported by R&D dept including research assistants Legacy: BrainFit

Objectives Primary objective: RCT to estimate the effects of an exercise/physical activity intervention that is feasible for delivery within the current constraints of National Health Service delivery. Secondary objectives were to: Complete a parallel cost study and conduct an economic analysis from a healthcare and societal perspective. Investigate intervention effects in pre-defined subgroups of gender and dementia severity.

Outcome Measures MMSE Bristol Activity of Daily Living scale Other outcomes included - Euro-QoL, EQ-5D, QoL, NPI, Mood - Cornell Scale for Depression in Dementia, Zarit Burden Interview

Inclusion criteria 1.Dementia 2.MMSE >10 3.Able to participate in a structured exercise programme: a) able to sit on a chair and to walk 10 feet without human assistance; b) no serious unstable illness (e.g. unstable angina) 4. Live in the community

Intervention Initial pre-assessment 1 x hour sessions of physiotherapy twice a week 30 minutes aerobic 30 minutes resistance Follow up telephone calls 16 week duration

Delivery Harold Hill Health Centre Equipment Training Supervision Transport Backfill costs

Recruitment Referrals from Memory Clinics, CST groups, Community Health services Screening (telephone), baseline, 6 months and 12 months 728 participants 364 Intervention 364 TAU 6 NELFT 6 NELFT Carers were included, so recruitment targets doubled Success of first group led to a second intervention group

Reflections - benefits 1.Increased research knowledge and experience with the clinical team 2.Developed relationships between Mental Health and Community Health Services 3.Increased skills of physiotherapists in working with people with dementia and their carers 4.Staff trained and assessed in use of wide range of measures 5.Participant feedback was very positive 6.Backfill payments to invest in additional resource 7.Carers involvement in supporting the intervention and networking 8.Legacy - BrainFit

Reflections - challenges 1.Managing expectations of participants when the groups finished 2.Time expectations 3.Meeting the demands of a busy service 4.Staffing changes and resources 5.Wanting to provide additional input adherence to intervention protocol 6.Managing expectations of those participants who were allocated to the control group 7.Identifying people with dementia interested in exercising using a bicycle 8.Unblinding of researchers

So can I take on a role as a PI? INVEST study Individual CST in Parkinson s disease dementia JR PI as oversight Delivery of study by R&D staff

So can I take on a role as a PI? Role varies a great deal between studies, many responsibilities can be delegated in some cases If interested it is worth speaking to Your own R&D dept CRN about studies that are potentially open to sites Support/resource may be available from R&D or CRN There are a lot of acronyms and regulatory systems More intense with more risk associated with the study Don t be put off others can help you navigate Speak to your R&D before agreeing to PI a study!